CAR T cell cancer immunotherapy, illustration

Numéro d’image : 12492772
CAR T cell cancer immunotherapy, illustration
CAR T cell cancer immunotherapy. Illustration of the membrane of a cell involved in CAR (chimeric antigen receptor) T cell immunotherapy, a process that is being developed to treat cancer. In this process, T cells (part of the immune system) are treated with a virus in a form of genetic engineering, resulting in them producing chimeric antigen receptor (CAR) proteins. These proteins will be specific to the patient's cancer. Here, these engineered receptors (light blue, one circled at top right) bind specifically to CD19-antigen molecules (purple), in this case on a leukaemia cell. This activates a signal cascade in the T-cell leading to the segregation of vesicles that contain perforin and granzyme (yellow) molecules. The perforins build channels for the granzymes which enter the leukaemia cell and trigger the apoptosis (cell death) of the cancer cell.
Licence : Droits gérés
Crédit: Science Photo Library / Gaertner, Juan
Taille de l’image : 6827 px × 5120 px
Model Release : Non requis
Property Release : Non requis
Restrictions : -

Prix pour cette image À partir de 45 €

Produit vendu
(Calendrier, Carte postale, Carte de vœux, Impression sur textile, Packaging etc)
À partir de 45 €
Usage commercial
(Affichage, Annonce presse, Annonce TV, Carte, Digital - hors rés. sociaux, Digital - rés. sociaux etc)
À partir de 45 €
Éditorial
(Digital, Journal, Livre, Livre pratique, Magazine, Télévision etc)
À partir de 60 €
Usage non-commercial
(Digital - hors rés. sociaux, Digital - rés. sociaux etc)
À partir de 120 €

Mots clés

;